- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
NETosis: A New Factor in Tumor Progression and Cancer-Associated Thrombosis ; volume:40 ; number:03 ; year:2014 ; pages:277-283
Seminars in thrombosis and hemostasis ; 40, Heft 03 (2014), 277-283
- Beteiligte Personen und Organisationen
-
Demers, Melanie
Wagner, Denisa D.
- DOI
-
10.1055/s-0034-1370765
- URN
-
urn:nbn:de:101:1-2019011009472001905658
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:04 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Demers, Melanie
- Wagner, Denisa D.
Ähnliche Objekte (12)
Cancer-associated thrombosis in Asia
Safety of Apixaban for Cancer-Associated Thrombosis
Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI
Erratum: Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI
Therapeutic Shifts in the Management of Cancer-Associated Thrombosis
Challenging Situations in the Treatment of Cancer-Associated Thrombosis
Proper application of anticoagulation therapy on cancer-associated venous thrombosis
Management of Cancer-Associated Thrombosis: Unmet Needs and Future Perspectives
Cancer-associated fibroblasts: a versatile mediator in tumor progression, metastasis, and targeted therapy
Dysfunctional adipocytes promote tumor progression through YAP/TAZ-dependent cancer-associated adipocyte transformation
Cancer-associated adipocytes: key players in breast cancer progression
Management of Cancer-Associated Venous Thrombosis: A Nationwide Survey among Danish Oncologists
Cancer-associated thrombosis in Asia
Safety of Apixaban for Cancer-Associated Thrombosis
Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI
Erratum: Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI
Therapeutic Shifts in the Management of Cancer-Associated Thrombosis
Challenging Situations in the Treatment of Cancer-Associated Thrombosis
Proper application of anticoagulation therapy on cancer-associated venous thrombosis
Management of Cancer-Associated Thrombosis: Unmet Needs and Future Perspectives
Cancer-associated fibroblasts: a versatile mediator in tumor progression, metastasis, and targeted therapy
Dysfunctional adipocytes promote tumor progression through YAP/TAZ-dependent cancer-associated adipocyte transformation
Cancer-associated adipocytes: key players in breast cancer progression
Management of Cancer-Associated Venous Thrombosis: A Nationwide Survey among Danish Oncologists
Cancer-associated thrombosis in Asia
Safety of Apixaban for Cancer-Associated Thrombosis
Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI
Erratum: Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI
Therapeutic Shifts in the Management of Cancer-Associated Thrombosis
Challenging Situations in the Treatment of Cancer-Associated Thrombosis
Proper application of anticoagulation therapy on cancer-associated venous thrombosis
Management of Cancer-Associated Thrombosis: Unmet Needs and Future Perspectives
Cancer-associated fibroblasts: a versatile mediator in tumor progression, metastasis, and targeted therapy
Dysfunctional adipocytes promote tumor progression through YAP/TAZ-dependent cancer-associated adipocyte transformation
Cancer-associated adipocytes: key players in breast cancer progression